ArticleJournal of applied clinical medical physics2026
A rule-based, feedback-driven framework for fully automated prostate VMAT planning.
Article in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundManual prostate volumetric modulated arc therapy (VMAT) planning in Elekta Monaco is complex, time-intensive, and prone to planner variability. Existing automation methods, such as knowledge-based planning (KBP) and cloud-based solutions often rely on external models rather than Monaco's native optimization. A treatment planning system (TPS)-integrated, feedback-driven approach could improve consistency and transparency while maintaining clinical quality. PURPOSE: To develop and validate a fully automated planning algorithm (APA) that actively interacts with Monaco via its application programming interface (API), mimicking expert user behavior during optimization to deliver consistent, high-quality plans.
methodsThe APA was developed as a rule-based, fully deterministic workflow within the Monaco TPS, leveraging its native constrained and multicriterial optimization framework to enable end-to-end automated VMAT prostate plan generation. A retrospective, paired dosimetric study was conducted on localized prostate cancer cases. For each patient, the clinically approved manual plan was compared to an automated plan generated by the APA. The workflow reads target and organ-at-risk (OAR) objectives from the plan, monitors Monaco's optimization feedback-including dose-volume histogram (DVH) metrics and cost-function weights-and iteratively adjusts objectives. Endpoints included target coverage, OAR dose metrics, complexity, conformity, and planning time.
resultsAutomated plans achieved non-inferior target coverage with a median difference in PTV V57 Gy of -0.275% (p = 0.116) between automated and manual plans. Automated plans produced statistically significant reductions in intermediate and low rectal doses including V40 Gy (1.62%, p = 0.003), V32 Gy (4.28%, p < 0.001), and V24 Gy (8.19%, p < 0.001), while high rectal doses (48-60 Gy) showed no statistically significant differences (p > 0.05). Similarly for the bladder, automated plans significantly reduced V48 Gy (4.07%, p < 0.001) and V40 Gy (2.91%, p < 0.001), with a modest increase in high dose bladder volume (V60 Gy +1.33%, p < 0.001). Mean execution time for automated plans was 38.7 ± 14.7 min per case, compared to an informally estimated manual planning time of 2 h at our institution. All automated plans met institutional clinical acceptability criteria.
conclusionsA TPS-native, feedback-driven automation using the Monaco Scripting API can replicate clinical planning strategies without human intervention, eliminating user variability and improving consistency. This approach offers a practical pathway for high-quality prostate VMAT planning in routine clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.